Recovery Capital Includes Cognitive Capital

If you or someone you know needs help with substance use, SAMHSA's National Helpline is 1-800-662-HELP (4357), free and confidential, 24 hours a day, every day. The 988 Suicide and Crisis Lifeline can be reached by call or text at 988.

Recovery capital is the sum of resources a person can draw on to start and sustain recovery. William White and William Cloud, writing for addictions professionals in 2008, define it as “the breadth and depth of internal and external resources that can be drawn upon” to begin recovery from serious alcohol and other drug problems and to keep it going. Cognitive capacity belongs in that sum, and it is the part nobody counts.

Recovery capital is an inventory of resources, and cognition sits inside it

White and Cloud sort recovery capital into three categories. Personal recovery capital, which they divide into physical capital and human capital. Family and social recovery capital, meaning the relationships a person can rely on. Community recovery capital, meaning what exists where the person lives: meetings, transportation, employers who will hire, services that answer the phone. The term itself traces to Robert Granfield and William Cloud's 1999 book on people who left addiction behind without formal treatment.

The reason the frame has lasted is that it asks a different question than a diagnosis does. A diagnosis describes what is wrong. An inventory of resources describes what a person has to work with, which is the question a case manager, an employer and a family member are all actually asking.

Human capital in that inventory covers values, skills, self-efficacy and a sense of purpose, which in practice means education, work skills, problem-solving and the capacity to carry out a plan. Attention, working memory and emotional regulation sit underneath every item on that list. A person keeping appointments, holding a job, learning a new trade and managing a hard afternoon is using cognitive capacity to do it. Counting that capacity as a resource follows the frame's own logic, and it is the argument this page makes.

Overdose deaths fell for a third straight year

CDC's provisional counts of drug overdose deaths now cover the 12 months ending in May 2026. The reported count for that window is 65,351, and CDC's predicted value, which adjusts for death records not yet complete, is 66,478. The same window a year earlier carried a predicted 75,094, so the 12-month total fell 11.5%.

Calendar 2025 closed at a predicted 70,735, against 81,313 in 2024, a decline of 13%. That is the third consecutive annual decline from the series peak of 110,393 in 2022. And 70,735 is the lowest calendar-year total CDC's provisional series has recorded since 2018.

The denominators matter more than the direction. Each figure is a rolling 12-month national total rather than a monthly count, so a decline described in one month's release is a comparison between two years. The predicted value runs above the reported count because reporting lags, and the gap closes as records complete. CDC's current file reflects data available for analysis as of Oct. 4, 2026. Most of all, a drop of 11.5% leaves 66,478 deaths in a single year, which is higher than any annual total the series recorded through 2016. The improvement is real, and the remaining annual total is very large.

Coverage has moved with the numbers, from emergency to fragile progress. The question it has largely stopped asking is what recovery requires once survival is no longer in doubt.

Employers are building recovery-ready programs, and the federal government wrote the manual

The “Recovery-Ready Workplace Toolkit: Guidance and Resources for Private and Public Sector Employers” was developed by the Office of National Drug Control Policy, the Domestic Policy Council and 12 federal departments and independent agencies, and it is published through the Recovery-Ready Workplace Resource Hub with support from the Department of Labor's Employment and Training Administration. It is free, and it is specific: policy language, manager training, hiring practice and measurement all sit in it.

State money is moving in the same direction. New Jersey's Department of Labor and Workforce Development announced $5 million in available funding under its Pathways to Recovery program on Feb. 12, 2026, with awards of up to $1 million over 24 months for training, career services, employment and supportive services such as transportation, child care and clothing. The program started in 2019 in six counties and went statewide in 2024. In July 2026, Integrity House, a Newark nonprofit, reported a $1 million award under the program covering seven counties.

An organization standing up one of these programs has a list of components to assemble. Universal wellness offerings are on that list, and they are usually the last item chosen and the least examined.

A benefit labeled for a condition asks the person to name the condition

The federal toolkit addresses this directly in its own material. It reports that people with a substance use disorder or in recovery have said they feared disclosing their status would carry negative consequences, that fear of lost standing with colleagues is part of it, and that psychological safety and trust in the employer are associated with willingness to disclose. On the practical consequence the toolkit is blunt. Where employees fear stigma, discrimination, discipline, termination or other negative impacts, it says, “they have a strong incentive to hide their SUD, rather than seeking help for it.”

That has a design consequence for anyone building a program. A benefit labeled for a condition asks the person to name the condition in order to use it. An offering open to the whole workforce requires no disclosure at the point of use, so the person who would not raise a hand for a recovery-specific benefit can use it without raising one.

This is an observation about who enrolls rather than a claim about what happens to them afterward. It is also the single most useful thing a general wellness program contributes to a recovery-ready plan, and it is worth saying plainly because it is the part that gets skipped when these programs are designed around clinical services alone.

Where Neurova Labs stops

Neurova Academy is a facilitator-led general wellness and cognitive training program from Neurova Labs, delivered on site by a certified facilitator. Four things it is not:

• It is not treatment for substance use disorder.

• It is not detox.

• It is not a relapse prevention program.

• It is not a program for which Neurova Labs reports any outcome in a recovery population.

Neurova Labs makes no claim that the program supports recovery from substance use disorder. We hold observational pilot findings from our own cohorts, we state the participant count and the study beside every figure we publish, and our full position on the evidence in this category is on our claims page.

What a treatment center, a recovery community organization or an employer can do is make a general wellness offering available to everyone it serves, without asking anyone to declare why they want it. Recovery capital asks what a person has to work with. Cognitive capacity belongs on that list, and it is worth counting.

Neurova Academy is a general wellness and cognitive training program. It is not a medical device and is not offered to diagnose, treat, cure, or mitigate any disease or condition, including concussion, traumatic brain injury, or CTE. Outcomes described reflect observational pilot findings and individual experience, and are not a prediction of results for anyone else. Individual results vary. Laboratory testing provided by iXpressGenes, a CLIA-certified, CAP-accredited laboratory.

Media contact: Nathaniel Free, chief communications officer, nathaniel.free@neurovalabs.com

Sources

White W, Cloud W. “Recovery capital: A primer for addictions professionals.” Counselor, 2008, 9(5), 22-27.

Granfield R, Cloud W. Coming Clean: Overcoming Addiction Without Treatment. New York University Press, 1999.

CDC, National Center for Health Statistics, VSRR Provisional Drug Overdose Death Counts. Figures computed from the published file, data available for analysis as of Oct. 4, 2026.

Federal Recovery-Ready Workplace Interagency Workgroup. “Recovery-Ready Workplace Toolkit: Guidance and Resources for Private and Public Sector Employers.” Published via the Recovery-Ready Workplace Resource Hub, U.S. Department of Labor, Employment and Training Administration.

New Jersey Department of Labor and Workforce Development, “NJ Labor Department Announces $5 Million in Available Grant Funding for Job Training and Support for Opioid-Impacted New Jerseyans,” Feb. 12, 2026.

NJBIZ, “Integrity House secures $1M opioid recovery workforce grant,” July 31, 2026.